UTZ Utz Brands posts modest Q4 2025 earnings beat shares edge higher on steady yearoveryear revenue growth Metagenomi Therapeutics MGX Stock Sentiment Analysis Weakens 20260422 BFS Saul Centers posts 45 percent Q3 2025 EPS miss with shares dipping 041 percent despite 78 percent revenue growth What New NMFCZ is doing that smart investors recognize Motionless 20260511